GL1X · GenesisL1 explorer

Research workbench

3ZTC: pVHL54-213-EloB-EloC complex _ (2S,4R)-N-((1,1'-biphenyl)-4-ylmethyl)- 4-hydroxy-1-(2-(3-methylisoxazol-5-yl)acetyl)pyrrolidine-2- carboxamide

Analyse 3ZTC: pVHL54-213-EloB-EloC complex _ (2S,4R)-N-((1,1'-biphenyl)-4-ylmethyl)… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3ZTC
Type
protein
Length
1,328 residues
Chains
12
Method
x-ray diffraction
Authors
Van Molle, I., Buckley, D.L., Crews, C.M., Ciulli, A.
Deposited
07/06/11
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.65
Source
HOMO SAPIENS
Molecule
Transcription elongation factor B polypeptide 2; Transcription elongation factor B…
UniProt
Q15370, Q15369, P40337
Ligands
TR0
Pockets
11 · best druggability 0.63

Structure

x-ray diffraction · resolution 2.65 · 11 distinct chains · 27% helix, 28% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATranscription elongation factor B polypeptide 2protein10318% helix, 35% strandQ15370
BTranscription elongation factor B polypeptide 1protein8648% helix, 15% strandQ15369
CVon hippel-lindau disease tumor suppressorprotein14123% helix, 30% strandP40337
DTranscription elongation factor B polypeptide 2protein9915% helix, 35% strandQ15370
E, KTranscription elongation factor B polypeptide 1protein8748% helix, 15% strandQ15369
FVon hippel-lindau disease tumor suppressorprotein14223% helix, 28% strandP40337
GTranscription elongation factor B polypeptide 2protein10524% helix, 36% strandQ15370
HTranscription elongation factor B polypeptide 1protein8648% helix, 15% strandQ15369
IVon hippel-lindau disease tumor suppressorprotein14526% helix, 29% strandP40337
JTranscription elongation factor B polypeptide 2protein10418% helix, 31% strandQ15370
LVon hippel-lindau disease tumor suppressorprotein14324% helix, 29% strandP40337

Ligands and binding sites

  • TR0 · (4R)-N-(biphenyl-4-ylmethyl)-4-hydroxy-1-[(3-methylisoxazol-5-yl)acetyl]-L-prolinamide · ligand · 4 copies · chains C, F, I, L

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

11 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13480.630.7944TR0
22960.620.7935TR0
31200.550.8223empty
41840.460.7536empty
5760.450.8117empty

Interfaces

17 interfaces between chains.

  • G–H · 1118 Ų buried · 16 hydrogen bonds · protein-protein
  • J–K · 1114 Ų buried · 10 hydrogen bonds · protein-protein
  • D–E · 1079 Ų buried · 11 hydrogen bonds · protein-protein
  • A–B · 1066 Ų buried · 13 hydrogen bonds · protein-protein
  • E–F · 1059 Ų buried · 13 hydrogen bonds · protein-protein

Compared structures

  • 3ZTC · PVHL54-213-elob-eloc complex _ (2S,4R)-N-((1,1'-biphenyl)-4-ylmethyl)… · the same entry in another collection · chain L against L, TM-score 1.00

Analyse

Other records of 3ZTC

  • 3ZTC-2 · MolNFT v1 / PDB · PVHL54-213-elob-eloc complex _ (2S,4R)-N-((1,1'-biphenyl)-4-ylmethyl)…

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.